Inhibition of protein synthesis reduces the cytotoxicity of 4'-(9-acridinylamino) methane-sulfon-m-anisidide without affecting DNA breakage and DNA topoisomerase ii in a murine mastocytoma cell line
- 1 January 1989
- journal article
- research article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 38 (2), 263-269
- https://doi.org/10.1016/0006-2952(89)90036-1
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Mechanism of resistance of non-cycling mammalian cells to 4′-[9-acridinylamino]methanesulphon-m-anisidide: Role of DNA topoisomerase II in log- and plateau-phase CHO cellsBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1988
- Topoisomerase-specific drug sensitivity in relation to cell cycle progression.Molecular and Cellular Biology, 1987
- Cell cycle stage-dependent variations in drug-induced topoisomerase II mediated DNA cleavage and cytotoxicityBiochemistry, 1987
- The interaction between nuclear topoisomerase II activity from human leukemia cells, exogenous DNA, and 4′-(9-acridinylamino) methanesulfon-m-anisidide (m-AMSA) or 4-(4,6-0-ethylidene-β-D-glucopyranoside) (VP-16) indicates the sensitivity of the cells to the drugsBiochemical and Biophysical Research Communications, 1987
- Proliferation dependence of topoisomerase II-mediated drug actionBiochemistry, 1986
- DNA topoisomerases as targets for cancer therapyBiochemical Pharmacology, 1985
- DNA topoisomerase II as a target of antineoplastic drug therapyCancer and Metastasis Reviews, 1985
- Adriamycin-Induced DNA Damage Mediated by Mammalian DNA Topoisomerase IIScience, 1984
- Dominant versus recessive behavior of a cold- and a heat-sensitive mammalian cell cycle variant in heterokaryonsSomatic Cell and Molecular Genetics, 1981
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976